In a filing, Castle Biosciences Inc revealed its Pres. & Chief Exec. Officer MAETZOLD DEREK J unloaded Company’s shares for reported $47704.0 on Oct 08 ’24. In the deal valued at $30.27 per share,1,576 shares were sold. As a result of this transaction, MAETZOLD DEREK J now holds 7,048 shares worth roughly $-0.24 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MAETZOLD DEREK J sold 986 shares, generating $29,845 in total proceeds. Upon selling the shares at $30.27, the Pres. & Chief Exec. Officer now owns 93,636 shares.
Before that, BRADBURY DANIEL sold 7,867 shares. Castle Biosciences Inc shares valued at $231,628 were divested by the Director at a price of $29.44 per share. As a result of the transaction, BRADBURY DANIEL now holds 5,700 shares, worth roughly $0.2 million.
Guggenheim initiated its Castle Biosciences Inc [CSTL] rating to a Buy in a research note published on December 14, 2023; the price target was $25. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Stephens began covering CSTL with “an Overweight” recommendation on January 07, 2022. Lake Street started covering the stock on April 30, 2021. It rated CSTL as “a Buy”.
Price Performance Review of CSTL
On Monday, Castle Biosciences Inc [NASDAQ:CSTL] saw its stock jump 9.42% to $34.26. Over the last five days, the stock has gained 16.06%. Castle Biosciences Inc shares have risen nearly 58.76% since the year began. Nevertheless, the stocks have risen 181.05% over the past one year. While a 52-week high of $32.53 was reached on 10/14/24, a 52-week low of $12.07 was recorded on 07/05/24. SMA at 50 days reached $28.83, while 200 days put it at $23.50.
Levels Of Support And Resistance For CSTL Stock
The 24-hour chart illustrates a support level at 32.30, which if violated will result in even more drops to 30.33. On the upside, there is a resistance level at 35.36. A further resistance level may holdings at 36.45. The Relative Strength Index (RSI) on the 14-day chart is 70.15, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.04, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.32%. Stochastics %K at 71.03% indicates the stock is a holding.
How much short interest is there in Castle Biosciences Inc?
A steep rise in short interest was recorded in Castle Biosciences Inc stocks on 2024-09-30, dropping by -0.16 million shares to a total of 1.61 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.77 million shares. There was a decline of -9.86%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
